Syngene's Bengaluru site damaged by fire

By Gareth Macdonald

- Last updated on GMT

Fire at Syngene site (source Syngene)
Fire at Syngene site (source Syngene)
A fire has damaged a facility operated by Indian contractor, Syngene International. 

According to a Syngene filing on the Bombay Stock Exchange (BSE), the fire at the site on the outskirts of Bengaluru started on Monday evening and lasted for three hours. 

Spokesman Sandeep Nair told us "We are in the process of assessing the extent of damage. Currently the site is shut down. There has been no injury or loss of life due to the fire​."

He added that: "We are conducting an inquiry to find the exact cause of the fire.​" 

Business impact

In its BSE statement Syngene said it "has implemented its Business Continuity Plan (BCP) to minimize impact on operations. Further, Syngene’s Industrial All Risk Insurance Policy will help minimize the financial impact on account of damage to assets and loss of profits​."

According to Nair the impact on Syngene's business has not yet been determined, although disruption is likely.

He told us "Based on our assessment of the extent of damage and the likely time it will take to restore normal operation, we will decide appropriate course of action. At this point it is a bit too early to comment​."

"There will be some interruption to the ongoing activities at this facility. However our efforts are to minimize the interruptions​" Nair added.

None of Syngene's other facilities at the campus were damaged by the fire and that all continue to operate normally.

Syngene was set up by Biocon in 2010. In 2015 the company was spun-out into a standalone entity​, raising $1.15bn (€1bn) in an IPO.

Related news

Show more

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Business Advice

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

Related suppliers

Follow us


View more